Head Cancer Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Head Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

SarcopeniaHead and Neck CancerHead Cancer+1 more
University of California, Davis20 enrolled2 locationsNCT06722508
Recruiting
Phase 2

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
University of Chicago30 enrolled1 locationNCT05420948
Recruiting
Phase 4

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Neuro Endocrine TumoursPDAC - Pancreatic Ductal AdenocarcinomaPancreas Adenocarcinoma+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)400 enrolled1 locationNCT07262957
Recruiting
Not Applicable

Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer

Pancreatic Ductal AdenocarcinomaPancreatic Head Cancer
Minia University90 enrolled1 locationNCT07232810
Recruiting
Phase 1

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHNSCC+3 more
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT04722523
Recruiting
Not Applicable

Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)

Chronic PainHead CancerNeck Cancer
University Hospital, Clermont-Ferrand120 enrolled1 locationNCT04673981
Recruiting

Evaluation of Quality of Life and Self-assurance and Social Support Earned for Non-cellular Head Cancer

Head Cancer
Andrzej Frycz Modrzewski Krakow University100 enrolled1 locationNCT06395805